SHORE-C

Menon U, Gentry-Maharaj A, Burnell M, Ryan A, Kalsi JK, Singh N, et al. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial, Health Technol Assess 2023. https://doi.org/10.3310/BHBR5832
Myall M, Taylor S, Wheelwright S, Lund S. Domestic Abuse in the Context of Life-Limiting Illness: A Systematic Scoping Review, Health & Social Care in the Community, Vol. 2023, Article ID 1841944, 24 pages, 10 April 2023
Torr B, Jones C, Choi S, Allen S, Kavanaugh G, Hamill M, Garrett A, MacMahon S, Loong L, Reay A, Yuan L, Petrizan M V, Monson K, Perry N, Fallowfield L, Jenkins V, Gold R, Taylor A, Gabe R, Wiggins J, Lucassen A, Manchanda R, Gandhi A, George A, Hubank M, Kemp Z, Evans G, Bremner S, Turnbull C A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot, Journal of Medical Genetics, Published 22 July 2022
Fallowfield L J, Solis-Trapala I, Starkings R, May S, Matthews L, Eccles D, Evans G, Turnbull C, Crawford G, Jenkins V Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING): development and evaluation of an educational programme for healthcare professionals about BRCA1 & BRCA2 testing, British Journal of Cancer, Published 17 June 2022
Di Maio M, Basch E, Denis F, Fallowfield L J, Ganz P A, Howell D, Kowalski D, Perrone F, Stover A M, Sundaresan P, Warrington L, Zhang L, Apostolidis K, Freeman-Daily J, Ripamonti C I, Santini D, on behalf of the ESMO Guidelines Committeee The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline, Annals of Oncology, Published 21 April 2022
Amdal C D, Taylor K Kuliś D, Falk R S, Bottomley A, Arraras J I, Barte J H, Darlington A S, Hofsø K, Holzner B, Høyning Jørgensen N M, Mariano M P, Pe M, Piccinin C, Riccetti N, Schranz M, Wheelwright S, Bjordal K Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure, Journal of Patient-Reported Outcomes, Published 26 March 2022
Fitzsimmons D, Wheelwright S Developing Cancer Quality of Life Assessment Tools, Handbook of Quality of Life in Cancer, Book Chapter, Published 26 March 2022
Glasspool R, Wheelwright S, Bolton V, Calman L, Cummings A, Elledge B, Foster R, Frankland J, Smith P, Stannard S, Turner J, Wright D, Foster C Modifiable pre-treatment factors are associated with quality of life in women with gynaecological cancers at diagnosis and one year later: Results from the HORIZONS UK national cohort study, Gynecologic Oncology, Published 26 March 2022
Read more about SHORE-C here >